Sparmvital
- Company typePrivate
- Founded2008
- HeadquartersHamar, Norway
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Sparmvital firmographics
Firmographics- Name
- Sparmvital
- Legal name
- SpermVital AS
- Website
- https://spermvital.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Sparmvital industry classification
Industry- Product category
- Animal Reproduction Biotechnology
- SIC
- Agricultural Prod-Livestock & Animal Specialties (200)
- akta.pro primary industry
- Artificial Insemination (AI) & Semen Collection/Distribution Services (AFAEAJAA)
- akta.pro secondary industries
- Artificial Insemination (AI) & Semen Services (Collection, Processing, Storage) (AFACAEAA), Reproductive & Breeding Devices & Supplies (AI Equipment, Pregnancy Detection Aids) (HLAMAFAM)
Keywords
Where Sparmvital is headquartered
LocationHeadquarters
- HQ city
- Hamar
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Sparmvital business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain
Revenue model
- Semen Extender Components: Sells component products (E1 Additive, E1 Concentrate, E2 Extender, Dissolving Solution, Gelling Agent) to approved partners and AI centers for production of SpermVital semen doses. Products are manufactured in Hamar, Norway and ordered through a partner portal.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | B2B component sales to approved partners |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Sparmvital product offering
Product offeringCore offering
SpermVital develops and sells a proprietary bovine semen preservation technology based on immobilizing sperm cells in alginate gel extracted from seaweed. The company manufactures and sells five processing components (E1 Additive, E1 Concentrate, E2 Extender, Dissolving Solution, and Gelling Agent) exclusively to approved AI centers and breeding companies, which use them to produce SpermVital semen doses. The technology extends sperm viability after insemination, providing a wider fertilization window and reducing insemination frequency.
Product overview
SpermVital offers a proprietary technology for long-term preservation of bovine semen, immobilizing sperm cells in alginate gel extracted from seaweed. The technology extends sperm longevity, allowing greater flexibility in insemination timing. The product portfolio consists of the core SpermVital Technology platform and five essential components: Dissolving Solution, E1 Additive, E1 Concentrate, E2 Extender, and Gelling Agent. These components are used by approved partners to produce SpermVital-processed semen doses. The company also offers a specialized sub-product, Trio+, developed with Geno SA, combining multiple bull genetics in one dose using the SpermVital technology. All products are manufactured at the company's facilities in Hamar, Norway.
Differentiator
Problem solved
Functional benefit
Products and services
- E1 Additive
- E1 Concentrate
- E2 Extender
- Dissolving Solution
- Gelling Agent
- Trio+
Quantifiable outcome
- 8.4% higher pregnancy rate in Italian field trial (41.9% vs 33.5% conception rate)
- +7 more outcomes
Companies that use Sparmvital
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles2 records
Sparmvital technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Sparmvital partnerships and signals
Strategic signalPartnerships
23 partnerships are on record, tiered core and minor.
- Geno SAcoreParent company of SpermVital AS. Geno SA is a major Norwegian livestock breeding organization. SpermVital is a subsidiary of Geno SA, established in 2008. The relationship enables distribution through Geno's global network including Geno Global and Geno Poland.
- VikingGeneticscoreCo-operative owned by 20,000 dairy and beef farmers in Denmark, Sweden, and Finland. Signed agreement to launch SpermVital technology on their own genetics, providing European farmers access to the technology on Viking genetics.
- Dovea GeneticscoreIreland's largest breeding company, offering SpermVital semen to its farmer members since spring 2023. Recently shared very positive results demonstrating improved fertility and increased flexibility in insemination practices.
- CRVcoreDutch cattle genetics company with shares in BelaVista (Brazil). Annual sales of over 4 million doses in Brazil. SpermVital visited BelaVista in October 2024 to produce sperm doses with their technology.
- Genostar Rinderbesamung GmbHcoreAustrian breeding company. Master's thesis data (2015-2019) showed SpermVital gave 6 percentage points higher non-return rate on heifers and 4.4 points on cows. Started selling SpermVital technology in autumn 2015.
- ABS Italy S.r.l.coreItalian distribution partner for SpermVital technology. Part of the Genus ABS global network.
- SwissgeneticsSwiss cattle breeding organization distributing SpermVital products in Switzerland.
- AlpengenetikminorAustrian partner distributing SpermVital technology.
- Oö Besamungsstation GmbHminorAustrian AI station partner.
- InoveominorBelgian partner for SpermVital distribution.
- FabacoreFinnish cattle breeding organization.
- RGB MemmingenminorGerman partner distributing SpermVital technology.
- SyneticsminorGerman partner.
- Genus ABScoreGlobal cattle genetics company with operations in UK and internationally.
- Nautastöd Bændasamtaka IslandsminorIcelandic breeding organization.
- FBI GENETICS S.A.S di Fabio Brotto & C.minorItalian genetics company.
- Geno PolandcorePolish subsidiary of Geno. Launched Trio+ product developed with SpermVital technology in Polish market in January 2026.
- PH KonradminorPolish partner.
- ABEREKIN S.A.minorSpanish breeding company.
- GB GeneticsminorItalian company owned by Giovanni Binotti. First buffalo production with SpermVital technology in December 2024. Collaborating to test and potentially optimize the product for buffalo.
- KGZS PreskaminorAI Center in Slovenia, key supplier of bovine semen for dairy and beef breeds. SpermVital completed successful production trip in February 2026. Doses are ready for field testing after quarantine.
- BelaVistaminorBrazilian company partially owned by CRV. SpermVital visited in October 2024 to produce sperm doses for Nelore breed. Brazil has over 200 million cattle but only 21% using artificial insemination.
- GenocoreLaunched Trio+ in Polish market - a new heterospermic semen product combining three bulls in one dose with SpermVital technology. Results show higher fertility (56-day non-return rate) compared to standard SpermVital.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Sparmvital competitors and assessment
Company assessmentBroad incumbents
- CRV: Dutch cattle genetics cooperative; partner through BelaVista Brazil (4M+ doses/yr). Comparable as a major European AI center producing and distributing bovine semen with proprietary technology, herd management and genetics services.
- Semex: Canadian bovine genetics cooperative marketing semen in 80+ countries. Comparable as a multinational cattle AI/genetics organization likely to encounter SpermVital's technology through its partners.
- Genus plc (ABS Global): Global bovine genetics leader operating ABS Global; partner of SpermVital in Italy via ABS Italy. Comparable as a cattle genetics platform with proprietary reproductive technology investments; much larger and offers full genetic lines rather than extender technology.
- Select Sires: U.S. farmer-owned cooperative producing and marketing bovine semen; one of the largest U.S. AI organizations. Comparable as a major AI center that would be a target customer/competitor for SpermVital in the U.S. market following CSS approval.
- VikingGenetics: Cooperative owned by ~20,000 dairy and beef farmers in Denmark, Sweden and Finland; SpermVital partner. Comparable as a Nordic/European AI cooperative offering proprietary bull genetics and semen to farmers.
- Masterrind: German AI cooperative and SpermVital customer (documented trial data). Comparable as a European AI organization producing and distributing bovine semen using SpermVital's extender technology.
Direct peers
- IMV Technologies: Global supplier of artificial insemination equipment, consumables and extender media for bovine and other species. Directly comparable as a B2B supplier of inputs (extenders, AI catheters, straws) used by AI centers, overlapping SpermVital's customer base.
- Minitube: German-headquartered supplier of reproductive technology products and services for animal breeding, including semen extenders, AI equipment and cryopreservation tools. Competes in the same B2B extender/AI-input category serving AI centers and breeding organizations globally.
- Cryogenetics: Co-located at the same Hamar Center for Breeding and Biotechnology; also founded by Professor Elisabeth Kommisrud; develops cryopreservation technologies for fish, livestock and human reproductive cells. Closely comparable reproductive-technology platform with overlapping R&D DNA and academic collaborators.
Others
- Geno SA: Parent company of SpermVital and Norwegian Red dairy genetics cooperative. Not a market competitor but the strategic controlling shareholder, channel partner (Geno Poland, Geno Global) and joint product developer (Trio+); critical for understanding SpermVital's go-to-market leverage and constraints.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Sparmvital compliance and trust
Trust signalCompliance1 record
Sparmvital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sparmvital leadership team
Management profileNumber of profiles
Profiles13 records
Sparmvital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sparmvital M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sparmvital
What does Sparmvital do?
SpermVital develops and sells a proprietary bovine semen preservation technology based on immobilizing sperm cells in alginate gel extracted from seaweed. The company manufactures and sells five processing components (E1 Additive, E1 Concentrate, E2 Extender, Dissolving Solution, and Gelling Agent) exclusively to approved AI centers and breeding companies, which use them to produce SpermVital semen doses. The technology extends sperm viability after insemination, providing a wider fertilization window and reducing insemination frequency.
Is Sparmvital a public or private company?
Sparmvital is a private company. It is classified as corporate owned and is currently operating.
When was Sparmvital founded?
Sparmvital was founded in 2008. It employs 11 to 50 people.
Where is Sparmvital based?
Sparmvital is headquartered in Hamar, Norway, in the Europe region.
How does Sparmvital make money?
One revenue line is on record: semen Extender Components.
Who are Sparmvital's main competitors?
Broad incumbents on record are CRV, Semex, Genus plc (ABS Global), Select Sires, VikingGenetics and Masterrind. Direct peers are IMV Technologies, Minitube and Cryogenetics. Geno SA is listed as an others.
Does Sparmvital have an API?
No public API is recorded for Sparmvital.
What industry is Sparmvital in?
Sparmvital's product category is Animal Reproduction Biotechnology. Its primary akta.pro industry code is AFAEAJAA, Artificial Insemination (AI) & Semen Collection/Distribution Services, with a secondary code of AFACAEAA, Artificial Insemination (AI) & Semen Services (Collection, Processing, Storage). Its SIC code is 200.